Company: BDRX
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001214659-25-006756
Chunk: 151

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-01
Form: DRS
Chunk 151
---
 or any document other than to “professional investors” within the meaning of Part I of Schedule 1 of the Securities
and Futures Ordinance (Cap.571, Laws of Hong Kong) (SFO) and any rules made thereunder, or in other circumstances which do not result
in the document being a “prospectus” within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong) (CO) or which
do not constitute an offer or invitation to the public for the purpose of the CO or the SFO, and (ii) no advertisement, invitation or
document relating to our shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether
in Hong Kong or elsewhere) which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong
(except if permitted to do so under the securities laws of Hong Kong) other than with respect to the shares which are or are intended
to be disposed of only to persons outside Hong Kong or only to “professional investors” within the meaning of the SFO and
any rules made thereunder.

| 81 |

<div align='center'>LEGAL MATTERS</div>

We are represented by Mintz, Levin, Cohn,
Ferris, Glovsky & Popeo, P.C., Boston, Massachusetts, with respect to certain legal matters of U.S. federal securities and New York
law. The validity of our Ordinary Shares underlying the Depositary Shares and certain matters governed by English law will be passed on
for us by Stephenson Harwood LLP, London, United Kingdom. The underwriter is being represented by .

<div align='center'>EXPERTS</div>

The financial statements as of December
31, 2024, and for the year then ended, incorporated by reference into this prospectus and in the registration statement have been so incorporated
in reliance on a report PKF Littlejohn LLP, an independent registered accounting firm, given on authority of said firm as experts in auditing
and accounting. The report on the financial statements for the year ended December 31, 2024 contains an explanatory paragraph regarding
our ability to continue as a going concern.

PKF Littlejohn LLP, London, United Kingdom,
is a member of the Institute of Chartered Accountants in England and Wales.

The financial statements as of December
31, 2023, and for each of the two years in the period then